Analgesic, Anesthetic, and Addiction
Clinical Trial Translations, Innovations,
Opportunities, and Networks

Effective July 1, 2011, IMMPACT consensus meetings, publications, and other activities will be conducted under the auspices of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the United States Food and Drug Administration.

Detailed information about ACTTION is available here.